Semaglutide is gaining traction as a groundbreaking treatment for type 2 diabetes. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist functions through stimulating the pancreas to release more insulin and reducing glucagon production. , Additionally, , semaglutide exhibits potential applications beyond diabetes management, spanning we… Read More